Experimental cholesterol drugs could reduce heart risk
SAN DIEGO - New research is boosting hope that a highly anticipated, experimental class of cholesterol drugs can greatly lower the risk for heart attacks, death and other heart-related problems.
Studies presented at a cardiology conference in San Diego today suggest that people taking one of these drugs had half the risk of dying or suffering a heart problem compared to others who were given the usual care.
However, side effects remain a question. The Food and Drug Administration will decide this summer whether to allow the drugs on the market.
Desktop NewsClick to open Continuous News in a sidebar that updates in real-time.
Legislation to address adoption costs still waiting on final approval
North Baton Rouge emergency room meets yearly projections in six months
Friends and family remember Billy Cannon
Governor John Bel Edwards sits down with 2une In to discuss the...
Police discuss recent rash of violent crimes in BR